References
- Ahmad, S. and Beg, Z.H., 2013. Hypolipidemic and antioxidant activities of thymoquinone and limonene in atherogenic suspension fed rats. Food chemistry, 138 (2–3), 1116–1124.
- Ahmad, S. and Beg, Z.H., 2014. Mitigating role of thymoquinone rich fractions from Nigella sativa oil and its constituents, thymoquinone and limonene on lipidemic-oxidative injury in rats. Springerplus, 3, 316.
- Alexandraki, K., et al., 2006. Inflammatory process in type 2 diabetes: the role of cytokines. Annals of the New York academy of sciences, 1084, 89–117.
- American Diabetes Association. 2012. Standards of medical care in diabetes. Diabetes care, 35(Suppl 1), S67–S74.
- Anderson, R.J., et al., 2001. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes care, 24 (6), 1069–1078.
- Anwer, T., et al., 2008. Effect of Withania somnifera on insulin sensitivity in non-insulin dependent diabetes mellitus (NIDDM) rat. Basic and clinical pharmacology and toxicology, 102, 498–503.
- Aswar, U., et al., 2017. Telmisartan attenuates diabetes induced depression in rats. Pharmacological reports, 69 (2), 358–364.
- Bani, I.A., 2015. Prevalence, knowledge, attitude and practices of diabetes mellitus among Jazan population, Kingdom of Saudi Arabia (KSA). Journal of diabetes mellitus, 5, 115–122.
- Braham, D. and Trinder, P., 1972. An improved colour reaction for the determination of blood glucose by oxidase system. Analyst, 97 (151), 142–145.
- Claiborne, A., 1985. Catalase activity. In: Greenwald, R.A (ed.). CRC handbook of methods for oxygen radical research. Boca Raton, FL: CRC Press, 283–284.
- da Silva Haeser, A., et al., 2007. Oxidative stress parameters in diabetic rats submitted to forced swimming test: the clonazepam effect. Brain research, 1154, 137–143.
- Dandona, P., et al., 2004. Inflammation: The link between insulin resistance, obesity and diabetes. Trends in immunology, 25 (1), 4–7.
- Darakhshan, S., et al., 2015. Thymoquinone and its therapeutic potentials. Pharmacological research, 95–96, 138–158.
- de Groot, M., et al., 2001. Association of depression and diabetes complications: a meta-analysis. Psychosomatic medicine, 63 (4), 619–630.
- Egede, L.E. and Ellis, C., 2006. Diabetes and depression: global perspectives. Diabetes research and clinical practices, 87, 302–312.
- Fouda, A.M., et al., 2008. Thymoquinone ameliorates renal oxidative damage and proliferative response induced by mercuric chloride in rats. Basic and clinical pharmacology and toxicology, 103, 109–118.
- Golden, S.H., et al., 2008. Examining a bidirectional association between depressive symptoms and diabetes. JAMA, 229, 2751–2759.
- Hilakivi-Clarke, L.A., et al., 1990. Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression. Physiology and behavior, 48 (3), 429–433.
- Islam, F., et al., 2002. Selenium induced alteration of lipids, lipid peroxidation and thiol group in circadian rhythm centers of rats. Biological trace element research, 90, 203–214.
- Jaiswal, A., et al., 2013. Therapeutic potential of thymoquinone against anti-tuberculosis drugs induced liver damage. Environmental toxicology and pharmacology, 36 (3), 779–786.
- Javed, H., et al., 2015. Effect of hisperidine on neurobehavioral, neuroinflammation, oxidative stress and lipid alteration in intracerebroventricular streptozotocin induced cognitive impairment in mice. Journal of the neurological sciences, 348 (2015), 51–59.
- Jollow, D.J., et al., 1974. Bromobenzene induced liver necrosis: Protective role of glutathione and evidence for 3, 4 – bromobenzene oxide as the hepatotoxic intermediate. Pharmacology, 11 (3), 151–169.
- Knol, M.J., et al., 2006. Depression as a risk factor for the onset of type 2 diabetes mellitus, A meta-analysis. Diabetologia, 49, 837–845.
- Lowry, O.H., et al., 1951. Protein measurements with the Folin’s reagent. The journal of biological chemistry, 193, 265–275.
- Maes, M., 2011. Depression is an inflammatory disease, but cell mediated immune activation is the key component of depression. Progress in neuropsychopharmacology and biological psychiatry, 35, 664–675.
- Mohandas, J., et al., 1984. Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer. Cancer research, 44, 5086–5091.
- Pari, L. and Sankaranarayanan, C., 2009. Beneficial effects of thymoquinone on hepatic key enzymes in streptozotocin-nicotinamide induced diabetic rats. Life science, 85, 830–834.
- Porsolt, R.D., et al., 1977. Behavioral despair in mice: A primary screening test for antidepressants. Archives international pharmacodynamie et de therapie, 229 (2), 327–336.
- Rebai, R., et al., 2017. The antidepressant effect of melatonin and fluoxetine in diabetic rats is associated with a reduction of the oxidative stress in the prefrontal and hippocampal cortices. Brain research bulletin, 134, 142–150.
- Safhi, M.M., 2016. Neuromodulatory effects of thymoquinone in extenuating oxidative stress in chlorpromazine treated rats. Acta poloniae pharmaceutica, 73 (2), 529–535.
- Shirwaikar, A., et al., 2005. Antidiabetic activity of alcoholic stem extract of Coscinium fenestratum in streptozotocin-nicotinamide induced type 2 diabetic rats. Journal of ethnopharmacology, 97 (2), 369–374.
- Talbot, F. and Nouwen, A., 2000. A review of the relationship between depression and diabetes in adults: Is there a link?. Diabetes care, 23 (10), 1556–1562.
- Utley, H.G., et al., 1967. Effect of sulfhydryl reagent on peroxidation in microsomes. Archives of biochemistry & biophysics, 118, 29–32.
- van Dooren, F.E., et al., 2013. Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis. PLoS one, 8 (3), e57058.
- Vijayapandi, P., et al., 2012. Depression like effects of telmisartan in mice forced swim test: involvement of brain dopaminergic system. Journal of pharmacology and toxicology, 7 (2), 87–95.
- WHO. 2016. Global report on diabetes. Geneva: World Health Organization.